RxDoctor Payments Data

Bruce Willner, DO

Family Medicine · Youngstown, OHNPI 1609853076

Payments from drug & device makers

$678in general payments, 2019–2025

Across 53 payments — averaging $12.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$145
  • Novo Nordisk$140
  • AstraZeneca$88
  • Sanofi-aventis U.S. LLC$74
  • Pfizer$61
  • Boehringer Ingelheim$40
  • plus $130 from 6 others

What the payments were for

  • Food & beverage$678100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$678 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$50,299
Medicare patients
177
Services billed
604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban294$168,557
FarxigaDapagliflozin Propanediol144$103,137
OzempicSemaglutide80$100,360
JardianceEmpagliflozin94$57,957
MounjaroTirzepatide38$46,365
RybelsusSemaglutide27$38,902
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$28,899
XareltoRivaroxaban61$28,148
Bydureon BciseExenatide Microspheres26$22,820
JanuviaSitagliptin Phosphate45$20,666
TrulicityDulaglutide12$15,766
Breo ElliptaFluticasone/Vilanterol22$12,236
LyricaPregabalin12$10,117
SymbicortBudesonide/Formoterol Fumarate27$7,766
TradjentaLinagliptin25$6,583

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Lyrica$61$178,673306 claims
Novo NordiskOzempic, Rybelsus$140$139,262107 claims
AstraZenecaFarxiga, Symbicort$88$110,904171 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$40$70,064131 claims
Lilly USA, LLCMounjaro, Trulicity$14$62,13250 claims
Johnson & JohnsonXarelto$24$28,14861 claims
MerckJanuvia$25$20,66645 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Youngstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →